CSL Behring Australia
A Principal Scientist in Molecular Biology at CSL Behring drives drug discovery and development for novel modalities, including gene editing and RNA therapeutics. This role involves designing complex experiments, establishing new technologies, and providing scientific oversight to advance candidates from early discovery through clinical development. The position requires deep expertise in genetic medicines and the ability to collaborate with academic and industry partners.
CSL Behring Australia is a biopharmaceutical leader driven by its promise to save and improve lives. We manufacture remedies for rare and serious conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CSL Behring Australia.
19% above the average for this role